Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.01 - Poster Session 1 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.01-011 - Targeting the Urokinase Plasminogen Activator (uPA) System to overcome cisplatin resistance in NSCLC
11:50 - 12:04 | Author(s): P. Godwin
- Abstract
Loading... -
+
P1.01-016 - Targeting NF-κB regulated pathways to overcome cisplatin resistance in non small cell lung cancer
13:00 - 13:14 | Author(s): A. Baird
- Abstract
Loading...
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-054 - Targeting MCL1 amplification in NSCLC through anthracycline-mediated transcriptional suppression
09:30 - 09:30 | Author(s): S. Busacca
- Abstract
Loading... -
+
P1.06-056 - Isolation & enumeration of Circulating Tumor Cells in Non-small Cell Lung Cancer, using Screencell & VitaAssay techniques.
09:30 - 09:30 | Author(s): J. O'Flaherty
- Abstract
Loading...
-
+
P1.21 - Poster Session 1 - Diagnosis and Staging
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 9
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.21-004 - Profiling the clinical and diagnostic pathway of Epidermal Growth Factor Receptor (EGFR) mutant Non-Small Cell Lung Cancer (NSCLC) in Ireland
09:30 - 09:30 | Author(s): J. Naidoo
- Abstract
Loading...
-
+
MO09 - Mesothelioma I
- Type: Mini Oral Abstract Session
- Track:
- Presentations: 14
- Moderators:K. Suzuki
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 204 A+B, Level 2
-
+
MO09.08 - NF-kB in cisplatin resistance and as a prognostic marker in Malignant pleural mesothelioma
16:55 - 17:00 | Author(s): K. Gately
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session 2 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 26
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.01-016 - Targeting the PI3K-mTOR-NFκB pathway to overcome cisplatin resistance in NSCLC.
09:30 - 09:30 | Author(s): S. Heavey
- Abstract
Loading...
-
+
P3.01 - Poster Session 3 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 21
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.01-012 - Co-targeting the PI3K and MEK pathways in NSCLC: an in vitro evaluation and mutation prevalence in an Irish patient cohort.
09:30 - 09:30 | Author(s): S. Heavey
- Abstract
Loading...
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-042 - Molecular Inequality in the Treatment of Non-Small Cell Lung Cancer (NSCLC) and Implications for Clinical Trials
09:30 - 09:30 | Author(s): J. Naidoo
- Abstract
Loading...
-
+
MO20 - Preclinical Therapeutic Models II
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 10
- Moderators:P. Waring
- Coordinates: 10/30/2013, 10:30 - 12:00, Bayside Gallery B, Level 1
-
+
MO20.03 - Development and characterization of a panel of GDC-0980 resistant NSCLC cell lines
10:40 - 10:45 | Author(s): S. Heavey
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
